Page last updated: 2024-08-23

pirfenidone and tetrathiomolybdate

pirfenidone has been researched along with tetrathiomolybdate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flaherty, KR; Lynch, JP; Martinez, FJ; Thannickal, VJ	1
Allen, J; Baran, CP; Bhatt, N; Magro, C; Marsh, CB	1

Reviews

2 review(s) available for pirfenidone and tetrathiomolybdate

Article	Year
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:8 Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Connective Tissue Growth Factor; Eicosanoids; Endothelin-1; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Molybdenum; Protein Kinase Inhibitors; Proteins; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Relaxin; Renin-Angiotensin System; Tumor Necrosis Factor-alpha	2004
Promising pharmacologic innovations in treating pulmonary fibrosis. Current opinion in pharmacology, 2006, Volume: 6, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antioxidants; Connective Tissue Growth Factor; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Molybdenum; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic	2006

Article

Year

Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.

Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:8

Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Connective Tissue Growth Factor; Eicosanoids; Endothelin-1; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Molybdenum; Protein Kinase Inhibitors; Proteins; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Relaxin; Renin-Angiotensin System; Tumor Necrosis Factor-alpha

2004

Promising pharmacologic innovations in treating pulmonary fibrosis.

Current opinion in pharmacology, 2006, Volume: 6, Issue:3

Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antioxidants; Connective Tissue Growth Factor; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Molybdenum; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic

2006